Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

Local biotech entrepreneurs and investors are seeing signs that the four-year "biotech winter" is finally thawing, though ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

This session examines Saudi Arabia’s value proposition as a regional manufacturing hub for healthcare and medical ...

The discussion focuses on how KAIMRC integrates clinical research, biobanking, data infrastructure, and translational science ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Carvykti sales surge, MRD FDA guidance speeds label expansion, and strong cash runway. Click for more on LEGN stock.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...